APPLICATION OF SALIVARY CONCENTRATION DATA TO PHARMACOKINETIC STUDIES WITH ANTIPYRINE

被引:60
作者
MEFFIN, PJ
WILLIAMS, RL
BLASCHKE, TF
ROWLAND, M
机构
[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARM,SAN FRANCISCO,CA 94132
[2] UNIV CALIF SAN FRANCISCO,DEPT PHARM,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94132
关键词
D O I
10.1002/jps.2600660140
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:135 / 137
页数:3
相关论文
共 23 条
[1]  
ANDREASEN PB, 1974, CLIN PHARMACOL THER, V16, P1059
[2]  
BRODIE BB, 1950, J PHARMACOL EXP THER, V98, P97
[3]   MECHANISM OF HEPATIC DRUG OXIDATION AND ITS RELATIONSHIP TO INDIVIDUAL DIFFERENCES IN RATES OF OXIDATION IN MAN [J].
DAVIES, DS ;
THORGEIRSSON, SS .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :411-+
[4]  
DAVIES DS, 1974, ASSESSMENT DRUG META
[5]  
DEANGELI.RL, 1974, FED PROC, V33, P534
[6]   SALIVARY EXCRETION OF PARACETAMOL IN MAN [J].
GLYNN, JP ;
BASTAIN, W .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :420-421
[7]   APPLICATION OF SALIVARY SALICYLATE DATA TO BIOPHARMACEUTICAL STUDIES OF SALICYLATES [J].
GRAHAM, G ;
ROWLAND, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (08) :1219-&
[8]  
HEWICK DS, 1974, ASSESSMENT DRUG META
[9]  
HUFFMAN DH, 1975, CLIN PHARMACOL THER, V17, P310
[10]  
KADAR D, 1973, CLIN PHARMACOL THER, V14, P552